{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:46:26Z","timestamp":1793893586017,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1C1C1012255"],"award-info":[{"award-number":["2020R1C1C1012255"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jneuroim.2020.577361","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T02:26:17Z","timestamp":1597458377000},"page":"577361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Serum level of IL-1\u03b2 in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD)"],"prefix":"10.1016","volume":"348","author":[{"given":"Young Nam","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boram","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyoung","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Beom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Sang","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Joon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jneuroim.2020.577361_bb0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clin. Sci. (Lond.)"},{"issue":"21","key":"10.1016\/j.jneuroim.2020.577361_bb0010","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577361_bb0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jri.2005.03.005","article-title":"Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants","volume":"66","author":"DuPont","year":"2005","journal-title":"J. Reprod. Immunol."},{"issue":"6337","key":"10.1016\/j.jneuroim.2020.577361_bb0020","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1126\/science.aal3535","article-title":"Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages","volume":"356","author":"Eddie Ip","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577361_bb0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","article-title":"Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"75","author":"Hacohen","year":"2018","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577361_bb0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00401-020-02132-y","article-title":"The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody","volume":"139","author":"H\u00f6ftberger","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577361_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00207450903428970","article-title":"Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients","volume":"120","author":"Icoz","year":"2010","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577361_bb0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577361_bb0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.jneuroim.2020.577361_bb0050","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.4049\/jimmunol.1202688","article-title":"IL-1\u03b2 promotes antimicrobial immunity in macrophages by regulating TNFR Signaling and caspase-3 activation","volume":"190","author":"Jayaraman","year":"2013","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577361_bb0055","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3892\/mmr.2013.1256","article-title":"Cytokine profile in relapsingremitting multiple sclerosis patients and the association between progression and activity of the disease","volume":"7","author":"Kallaur","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577361_bb0060","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jnnp-2018-317969","article-title":"CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications","volume":"89","author":"Kaneko","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577361_bb0065","first-page":"223","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease","volume":"8","author":"Kidd","year":"2003","journal-title":"Altern. Med. Rev."},{"issue":"12","key":"10.1016\/j.jneuroim.2020.577361_bb0070","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1007\/s00415-011-6086-x","article-title":"Cerebrospinal fluid\/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica","volume":"258","author":"Kim","year":"2011","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2020.577361_bb0075","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000163","article-title":"Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS","volume":"2","author":"Kim","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"8","key":"10.1016\/j.jneuroim.2020.577361_bb0080","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1177\/1352458516674366","article-title":"Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G","volume":"23","author":"Kim","year":"2017","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577361_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149411","article-title":"B cell, Th17, and neutrophil related cerebrospinal fluid cytokine\/chemokines are elevated in MOG antibody associated demyelination","volume":"11","author":"Kothur","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jneuroim.2020.577361_bb0090","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577361_bb0095","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000600","article-title":"Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis","volume":"6","author":"Kwon","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577361_bb0100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41467-019-08482-w","article-title":"Pathogenic function of bystander-activated memory-like CD4+ T cells in autoimmune encephalomyelitis","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577361_bb0105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12974-018-1335-x","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies","volume":"15","author":"Lee","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577361_bb0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/brbi.1995.1032","article-title":"Interleukin-1, nitric oxide and reactive astrocytes","volume":"9","author":"Lee","year":"1995","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577361_bb0115","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1309\/AJCP7UBK8IBVMVNR","article-title":"Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay","volume":"136","author":"Martins","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"issue":"25","key":"10.1016\/j.jneuroim.2020.577361_bb0120","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1901981","article-title":"Placebo-controlled trial of an Oral BTK inhibitor in multiple sclerosis","volume":"380","author":"Montalban","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577361_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","article-title":"Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported","volume":"261","author":"Petzold","year":"2014","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577361_bb0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577361_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/neup.12235","article-title":"TMEM119 marks a subset of microglia in the human brain","volume":"36","author":"Satoh","year":"2016","journal-title":"Neuropathology"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577361_bb0140","first-page":"82","article-title":"Optic neuritis: a review","volume":"16","author":"Shams","year":"2009","journal-title":"Int. MS J."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577361_bb0145","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000257","article-title":"Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis","volume":"3","author":"Spadaro","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2020.577361_bb0150","doi-asserted-by":"crossref","first-page":"577021","DOI":"10.1016\/j.jneuroim.2019.577021","article-title":"The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement","volume":"336","author":"Sugimoto","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"16 Suppl 2","key":"10.1016\/j.jneuroim.2020.577361_bb0155","first-page":"S23","article-title":"Acute disseminated encephalomyelitis","volume":"68","author":"Tenembaum","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577361_bb0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2017","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2020.577361_bb0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","author":"Transverse Myelitis Consortium Working Group","year":"2002","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jneuroim.2020.577361_bb0170","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6","volume":"16","author":"Uzawa","year":"2010","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577361_bb0175","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2222.1992.tb03097.x","article-title":"Effect of corticosteroid treatment on interleukin-1 and tumour necrosis factor secretion by monocytes from subjects with asthma","volume":"22","author":"Vecchiarelli","year":"1992","journal-title":"Clin. Exp. Allergy"},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577361_bb0180","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577361_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"15 Supplement","key":"10.1016\/j.jneuroim.2020.577361_bb0190","article-title":"Efficacy of satralizumab (SA237) in subgroups of patients in SAkuraSky: a phase III double-blind, placebo-controlled, add-on study in patients with neuromyelitis optica spectrum disorder (NMOSD)","volume":"92","author":"Yamamura","year":"2019","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577361_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162900","article-title":"Accuracy of the fluorescence-activated cell sorting assay for the Aquaporin-4 antibody (AQP4-ab): comparison with the commercial AQP4-ab assay kit","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577361_bb0200","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820301843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820301843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:37:51Z","timestamp":1759048671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572820301843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":40,"alternative-id":["S0165572820301843"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577361","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum level of IL-1\u03b2 in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD)","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"577361"}}